Emactuzumab

DB14905InvestigationalProtein Based Therapies

Emactuzumab is under investigation in clinical trial NCT01494688 (A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors).

Mechanism: Pharmacologically active on Macrophage colony-stimulating factor 1 receptor
Curator reviewed
Code names: RG7155 · RO5509554

Resolves to

Compound

UNII6FY6EI1X8RCAS1448221-67-7

Targets

P07333CSF1R

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

7Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Emactuzumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account